Comparison 12. Secukinumab vs placebo.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Proportion of participants with adverse effects in the short term | 1 | 157 | Risk Ratio (M‐H, Random, 95% CI) | 3.29 [1.40, 7.75] |
2 Proportion of participants achieving a 50% reduction in disease severity in the short term | 1 | 157 | Risk Ratio (M‐H, Random, 95% CI) | 1.55 [1.02, 2.35] |